Literature DB >> 15276029

Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes.

Timothy J Kemp1, Ioanna-Katerina Aggeli, Peter H Sugden, Angela Clerk.   

Abstract

Cardiac hypertrophy is associated with hypertrophic growth of cardiac myocytes and increased fibrosis. Much is known of the stimuli which promote myocyte hypertrophy and the changes associated with the response, but the links between the two are largely unknown. Using subtractive hybridization, we identified three genes which are acutely (<1 h) upregulated in neonatal rat ventricular myocytes exposed to the alpha-adrenergic agonist, phenylephrine. One represented connective tissue growth factor (CTGF) which is implicated in fibrosis and promotes hypertrophy in other cells. We further examined the expression of CTGF mRNA and protein in cardiac myocytes using quantitative PCR and immunoblotting, confirming that phenylephrine increased CTGF mRNA (maximal within 1 h) and protein (increased over 4 - 24 h). Endothelin-1 promoted a greater, though transient, increase in CTGF mRNA, but the increase in CTGF protein was sustained over 8 h. Neither agonist increased CTGF mRNA in cardiac non-myocytes. By increasing the expression of CTGF in cardiac myocytes, hypertrophic agonists such as phenylephrine and endothelin-1 may promote fibrosis. CTGF may also propagate the hypertrophic response initiated by these agonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276029     DOI: 10.1016/j.yjmcc.2004.04.022

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.

Authors:  Modar Kassan; Maria Galán; Megan Partyka; Zubaida Saifudeen; Daniel Henrion; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-26       Impact factor: 8.311

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 3.  Mineralocorticoid antagonism and cardiac hypertrophy.

Authors:  Kohzo Nagata
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

4.  Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a three-dimensional microtissue environment.

Authors:  C M Kofron; T Y Kim; M E King; A Xie; F Feng; E Park; Z Qu; B-R Choi; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

5.  Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells.

Authors:  Nynke E Hahn; René J P Musters; Jan M Fritz; Patrick J Pagano; Alexander B A Vonk; Walter J Paulus; Albert C van Rossum; Christof Meischl; Hans W M Niessen; Paul A J Krijnen
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

6.  Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.

Authors:  Karen A Ryall; Vassilios J Bezzerides; Anthony Rosenzweig; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2014-03-05       Impact factor: 5.000

7.  mTOR Complexes Repress Hypertrophic Agonist-Stimulated Expression of Connective Tissue Growth Factor in Adult Cardiac Muscle Cells.

Authors:  Kamala Sundararaj; Dorea L Pleasant; Phillip C Moschella; Kavin Panneerselvam; Sundaravadivel Balasubramanian; Dhandapani Kuppuswamy
Journal:  J Cardiovasc Pharmacol       Date:  2016-02       Impact factor: 3.105

8.  Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure.

Authors:  Yevgeniya E Koshman; Nilamkumar Patel; Miensheng Chu; Rekha Iyengar; Taehoon Kim; Cagatay Ersahin; William Lewis; Alain Heroux; Allen M Samarel
Journal:  J Card Fail       Date:  2013-03-19       Impact factor: 5.712

Review 9.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

10.  Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes.

Authors:  Xiaoyu Wang; Susan V McLennan; Terri J Allen; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2010-02-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.